Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Diabetes Mellitus, Type 2 3 Pulmonary Disease, Chronic Obstructive 1 Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Lung Neoplasms 1 Disease 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Metformin 152 Clomiphene 52 Letrozole 41 Inositol 34 Folic Acid 18 Progesterone 17 Exercise 17 Ethinyl Estradiol 13 Estradiol 13 Chorionic Gonadotropin 13 Caloric Restriction 13 drospirenone and ethinyl estradiol combination 12 Contraceptives, Oral 12 cetrorelix 11 Pioglitazone 10 High-Intensity Interval Training 10 Cholecalciferol 10 Triptorelin Pamoate 9 Tablets 9 Spironolactone 9 Menotropins 8 Diet 8 Vitamin D 7 Thioctic Acid 7 Surveys and Questionnaires 7 Liraglutide 7 Gonadotropins 7 Acupuncture Therapy 7 follitropin alfa 6 drospirenone 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Polycystic Ovary Syndrome × Dipeptidyl-Peptidase IV Inhibitors × Clear all

NCT02022007 2017-06-28

BMS-AZPCOS

Woman's

Phase 3 Completed

38 enrolled 17 charts

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡